Disease Categories Offered

Genomic testing stands as a beacon of hope, illuminating the genetic underpinnings of Metabolic Disorders. By deciphering the intricate tapestry of an individual's DNA, we can unlock a deeper understanding of the factors contributing to metabolic imbalances, paving the way for more personalized and targeted approaches to diagnosis, treatment, and prevention.

At the forefront of this revolution is GCR's pioneering Metabolic Disorders platform, an innovative tool that empowers healthcare professionals to delve into an individual's genetic makeup, pinpointing any variations or mutations that could hold the key to metabolic disorders. Armed with this valuable information, we can achieve early and accurate diagnoses and tailor treatment strategies to each patient's unique genetic profile.

The implications of this personalized approach are profound. By understanding the genetic basis of metabolic disorders, we can potentially delay or even prevent the onset of these conditions, empowering individuals to take control of their health and lead fulfilling lives

GCR's Metabolic Disorders platform represents a paradigm shift in the management of metabolic disorders, transforming the landscape of healthcare and ushering in an era of personalized medicine that has the potential to revolutionize the lives of countless individuals.

Therapeutics

Navigating the Therapeutic Landscape

Empower your treatment decisions with a comprehensive guide to FDA-approved targeted therapies based on genomic biomarkers.

Key Points

  • Uncover personalized treatment options tailored to your unique genetic profile.
  • Explore the latest FDA-approved therapies backed by robust clinical evidence.
  • Gain insights into the science behind genomic biomarkers and their impact on treatment response.
  • Navigate the complex therapeutic landscape with confidence and informed decision-making.

Pharmacogenomics

Embrace Personalized Therapeutics: Tailored Treatment for a Healthier You

Our cutting-edge precision medicine platform harnesses the power of genetic information to revolutionize healthcare. By analyzing your unique genetic makeup, we can provide personalized treatment plans that are safer, more effective, and tailored to your individual needs.

Key Benefits

  • Prevent Over-dosing and Under-dosing: Accurately determine the most effective drug dosages based on your genetics, minimizing side effects and maximizing treatment outcomes.
  • Personalized Treatment Plans: Identify the most effective drugs for your specific genetic makeup, ensuring optimal treatment efficacy and reducing adverse reactions.
  • Empowering Patients: Make informed healthcare decisions guided by genetic insights, taking charge of your health for a brighter future.

Prevalence

Metabolic disorders are a global health concern, affecting an estimated one-third of the world's adult population. This number is projected to increase as the global population ages and the burden of chronic diseases rises. Metabolic disorders are among the leading causes of preventable deaths and disabilities, posing a significant challenge to individuals and societies.

Some Common Metabolic Disorders Include

  • Dyslipidemia, a disorder of abnormal cholesterol and triglyceride levels, affects an estimated 60% of adults worldwide.
  • Non-alcoholic fatty liver disease (NAFLD), a condition characterized by fat buildup in the liver, affects an estimated 25% of adults worldwide.
Covered Disease Types and Sub-Types

  • Bartter Disease Type 1
  • Bartter Disease Type 2
  • Bartter Disease Type 3
  • Bartter Disease Type 4A
  • Bartter Disease Type 4B
  • Bartter Disease Type 5

  • Congenital Disorder Of Glycosylation Type 1C
  • Congenital Disorder Of Glycosylation Type 1E
  • Congenital Disorder Of Glycosylation Type IAA
  • Congenital Disorder Of Glycosylation Type ICC
  • Congenital Disorder Of Glycosylation Type IIq
  • Congenital Disorder Of Glycosylation Type IIr
  • Congenital Disorder Of Glycosylation Type IIt
  • Congenital Disorder Of Glycosylation With Defective Fucosylation 1
  • Congenital Disorder Of Glycosylation With Defective Fucosylation 2

  • Gaucher Disease Perinatal Lethal
  • Gaucher Disease Type 1
  • Gaucher Disease Type 2
  • Gaucher Disease Type 3
  • Gaucher Disease-Ophthalmoplegia-Cardiovascular Calcification Syndrome

  • Homocystinuria Due To MTHFR Deficiency
  • Homocystinuria Without Methylmalonic Aciduria

  • Niemann-Pick Disease Type A
  • Niemann-Pick Disease Type B
  • Niemann-Pick Disease Type C
  • Niemann-Pick Disease Type C1
  • Niemann-Pick Disease Type C2